GABRB1
Gamma-aminobutyric acid receptor subunit beta-1
Also known as: GBRB1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P18505
- Gene
- GABRB1
- Ensembl
- ENSG00000163288
- Chromosome
- 4
- Canonical length
- 474 aa
- Protein class
- Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
The gamma-aminobutyric acid (GABA) A receptor is a multisubunit chloride channel that mediates the fastest inhibitory synaptic transmission in the central nervous system. This gene encodes GABA A receptor, beta 1 subunit. It is mapped to chromosome 4p12 in a cluster comprised of genes encoding alpha 4, alpha 2 and gamma 1 subunits of the GABA A receptor. Alteration of this gene is implicated in the pathogenetics of schizophrenia. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
474 residues, UniProt reviewed canonical sequence.
>P18505|GABRB1
1 MWTVQNRESL GLLSFPVMIT MVCCAHSTNE PSNMSYVKET VDRLLKGYDI RLRPDFGGPP
61 VDVGMRIDVA SIDMVSEVNM DYTLTMYFQQ SWKDKRLSYS GIPLNLTLDN RVADQLWVPD
121 TYFLNDKKSF VHGVTVKNRM IRLHPDGTVL YGLRITTTAA CMMDLRRYPL DEQNCTLEIE
181 SYGYTTDDIE FYWNGGEGAV TGVNKIELPQ FSIVDYKMVS KKVEFTTGAY PRLSLSFRLK
241 RNIGYFILQT YMPSTLITIL SWVSFWINYD ASAARVALGI TTVLTMTTIS THLRETLPKI
301 PYVKAIDIYL MGCFVFVFLA LLEYAFVNYI FFGKGPQKKG ASKQDQSANE KNKLEMNKVQ
361 VDAHGNILLS TLEIRNETSG SEVLTSVSDP KATMYSYDSA SIQYRKPLSS REAYGRALDR
421 HGVPSKGRIR RRASQLKVKI PDLTDVNSID KWSRMFFPIT FSLFNVVYWL YYVHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GABRB1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 13 nTPM
- basal ganglia: 3.7 nTPM
- heart muscle: 3.4 nTPM
- amygdala: 2.4 nTPM
- retina: 2.3 nTPM
- hypothalamus: 1.4 nTPM
Single-cell type
- bergmann glia: 2,573 nCPM
- astrocytes: 1,326 nCPM
- other brain neurons: 739 nCPM
- brain inhibitory neurons: 654 nCPM
- brain excitatory neurons: 482 nCPM
- lactotrophs: 477 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 105 nTPM
- hypothalamus: 104 nTPM
- basal ganglia: 101 nTPM
- amygdala: 90 nTPM
- hippocampal formation: 84 nTPM
- midbrain: 67 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GABRB1.
Disease | AllUniProt
Conditions GABRB1 is implicated in, by any mechanism.
- Developmental and epileptic encephalopathy 45 (DEE45) MIM:617153
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 446 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Developmental and epileptic encephalopathy, 45
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.31
- gnomAD pLI
- 0.98
- gnomAD missense Z
- 2.65
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to histamine
- central nervous system neuron development
- chloride transmembrane transport
- gamma-aminobutyric acid signaling pathway
- monoatomic ion transport
- ovulation cycle
- response to progesterone
- response to toxic substance
- signal transduction
- synaptic transmission, GABAergic
Molecular functions
- G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential
- GABA receptor binding
- GABA-A receptor activity
- GABA-gated chloride ion channel activity
- ligand-gated monoatomic ion channel activity
- ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential
- transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Gamma-aminobutyric-acid A receptor, beta subunit
- Gamma-aminobutyric acid A receptor/Glycine receptor alpha
- Neurotransmitter-gated ion-channel transmembrane domain
- Neurotransmitter-gated ion-channel
- Neurotransmitter-gated ion-channel ligand-binding domain
- Neurotransmitter-gated ion-channel, conserved site
- Neurotransmitter-gated ion-channel transmembrane domain superfamily
- Neurotransmitter-gated ion-channel ligand-binding domain superfamily
- Neuronal acetylcholine receptor
- Neurotransmitter-gated ion-channel ligand binding domain
- Neurotransmitter-gated ion-channel transmembrane region
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GABRB1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GABRB1 as an antibody target. Whether an autoantibody or antibody against GABRB1 could matter depends on whether native GABRB1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GABRB1 is annotated at the cell surface, where native GABRB1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GABRB1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...